CONFERENCE REPORTER Jonathan E. Alpert, MD, PhD, the vice chair of the Future DSM Committee, explored the meaning behind the name change of the upcoming, new DSM, at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting in Miami, FL. The American Psychiatric Association released plans for a new edition of the DSM earlier this year.1,2 This new edition aims to address the shortcomings and critiques of previous editions.